Skip to main content
eScholarship
Open Access Publications from the University of California

UCLA

UCLA Previously Published Works bannerUCLA

Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol.

  • Author(s): Fu, Yue
  • Estoppey, David
  • Roggo, Silvio
  • Pistorius, Dominik
  • Fuchs, Florian
  • Studer, Christian
  • Ibrahim, Ashraf S
  • Aust, Thomas
  • Grandjean, Frederic
  • Mihalic, Manuel
  • Memmert, Klaus
  • Prindle, Vivian
  • Richard, Etienne
  • Riedl, Ralph
  • Schuierer, Sven
  • Weber, Eric
  • Hunziker, Jürg
  • Petersen, Frank
  • Tao, Jianshi
  • Hoepfner, Dominic
  • et al.
Abstract

Biosynthesis of glycosylphosphatidylinositol (GPI) is required for anchoring proteins to the plasma membrane, and is essential for the integrity of the fungal cell wall. Here, we use a reporter gene-based screen in Saccharomyces cerevisiae for the discovery of antifungal inhibitors of GPI-anchoring of proteins, and identify the oligocyclopropyl-containing natural product jawsamycin (FR-900848) as a potent hit. The compound targets the catalytic subunit Spt14 (also referred to as Gpi3) of the fungal UDP-glycosyltransferase, the first step in GPI biosynthesis, with good selectivity over the human functional homolog PIG-A. Jawsamycin displays antifungal activity in vitro against several pathogenic fungi including Mucorales, and in vivo in a mouse model of invasive pulmonary mucormycosis due to Rhyzopus delemar infection. Our results provide a starting point for the development of Spt14 inhibitors for treatment of invasive fungal infections.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View